---
title: "Sage Therapeutics GAAP EPS of -$1.56 misses by $0.03, revenue of $12.81M misses by $1.56M"
date: "2025-02-12 00:14:16"
summary: "Sage Therapeutics press release (NASDAQ:SAGE): Q4 GAAP EPS of -$1.56  misses by $0.03. Revenue of $12.81M (-83.6% Y/Y)  misses by $1.56M."
categories:
  - "seekalpha"
lang:
  - "en"
translations:
  - "en"
tags:
  - "seekalpha"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

* Sage Therapeutics [press release](https://seekingalpha.com/pr/19999013-sage-therapeutics-announces-fourth-quarter-and-full-year-2024-financial-results-and) (NASDAQ:[SAGE](https://seekingalpha.com/symbol/SAGE "Sage Therapeutics, Inc.")): Q4 GAAP EPS of -$1.56  misses by $0.03.
* Revenue of $12.81M (-83.6% Y/Y)  misses by $1.56M.

[seekalpha](https://seekingalpha.com/news/4406422-sage-therapeutics-gaap-eps-of-1_56-misses-by-0_03-revenue-of-12_81m-misses-by-1_56m)
